| CUPRAC | Cupric reducing antioxidant capacity |
| DMSO | Dimethyl sulfoxide |
| DN | Diabetic neuropathy |
| DPPH | 2,2-diphenyl-1-picrylhydrazyl |
| Fr. | Fraction |
| GAE | Gallic acid equivalents |
| GC-MS | Gas chromatography-mass spectrometry |
| HPLC-DAD | High-performance liquid chromatography–diode array detection |
| HUEF | Hacettepe University Faculty of Pharmacy |
| IC50 | Half-maximal inhibitory concentration |
| LC-MS | Liquid chromatography-mass spectrometry |
| LC-QTOF-MS | Liquid chromatography–quadrupole time-of-flight mass spectrometry |
| ND | Not detected |
| NMR | Nuclear magnetic resonance |
| PCA | Principal component analysis |
| pNPG | p-nitrophenyl-α-D-glucopyranoside |
| QE | Quercetin equivalents |
| RC50 | 50% radical-scavenging concentration |
| RP-VLC | Reversed-phase vacuum liquid chromatography |
| TLC | Thin-layer chromatography |
| UV | Ultraviolet |